Screening for Hepatitis B and C in Occupational Settings: Cross-Sectional Study about 4268 Corporates Agents in Côte d’Ivoire
- 1 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 2 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 3 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 4 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 5 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 6 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 7 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 8 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
- 9 Teaching Hospital Center of Cocody, Abidjan, Côte d’Ivoire
Abstract
Aim: To screen hepatitis B and C in occupational setting. Methods: Cross-sectional study multicenter in 16 enterprises (one occupational exposure; 5602 agents). Screening was preceded by information, sensibilisation and informed consenting physician labor, labor union and agents. Hepatitis B surface antigen (HBsAg) and antibodies anti-hepatitis C (Elisa, third generation) were tested in all. For those with HBsAg positive, this test was completed by IgM and IgG, anti HBc, HBeAg, antibodies anti HBe, transaminases and HBB DNA; for those with positive anti-VHC antibodies, test was completed by transaminases and VHC’s RNA. Results: Rate of participation was 76.2% (4268/5602 labors). HBsAg or hepatitis C antibodies were positives in 425 (9.9%) of cases (HBsAg positive: 8.48%; Hepatitis C Antibodies positives: 1.50%; both: 0.05%). In HBsAg positive, viral replication and cytolysis were seen respectively in 2.5 % and 18.2%. According with transaminases, serologic markers and viral load, immunotolerance, inactive and immuno active phase were suspected in 0.56%, 80.9% and 1.6% of cases. In hepatitis C antibodies positives persons, any had viral replication but cytolysis was observed in 33.3% (n = 21). HBsAg was significantively (p < 0.00001) higher in exposed occupational enterprise versus non-occupational setting (14.4% vs 7.8%). They were no differences (p = 0.71) about hepatitis C antibodies in the two setting (1.8% vs 1.7%). Conclusion: Prevalence of HBsAg and hepatitis C antibodies was high in occupational setting in hepatitis endemic country. It’s important to screen all of person in these setting with no consideration with blood exposed or not exposed enterprise.
- Lemoine, M., Eholié, S. and Lacombe, K. (2015) Reducing the Neglected Burden of Viral Hepatitis in Africa: Strategies for a Global Approach. Journal of Hepatology, 62, 469-476. https://doi.org/10.1016/j.jhep.2014.10.008
- Assi, C., Ouattara, A., Allah-Kouadio, E., Diakite, M., Koné, S., Lohoues-Kouacou M.J., et al. (2011) Vaccination Coverage against Hepatitis B and Prevalence of HBsAg: A Cross-Sectional Study Involving 592 Persons Attending Public Screening in Abidjan. Clinics and Research in Hepatology and Gastroenterology, 35, 506-507. https://doi.org/10.1016/j.clinre.2011.02.010
- Riou, J., Aït-Ahmed, M., Blake, A., Vozlinsky, S., Brichler, S., Eholié, S., et al. (2016) HCV Epidemiology in Africa Group. Journal of Viral Hepatitis, 23, 244-255. https://doi.org/10.1111/jvh.12481
- Rouet, F., Chaix, M.L., Inwoley, A., Msellati, P., Viho, I., Combe, P., et al. (2004) ANRS 1236 DITRAME-B&C Study Group. HBV and HCV Prevalence and Viraemia in HIV-Positive and HIV-Negative Pregnant Women in Abidjan, Côte d'Ivoire: the ANRS 1236 Study. Journal of Medical Virology, 74, 34-40. https://doi.org/10.1002/jmv.20143
- Pourette, D. and Enel, C. (2014) Representations and Disease Experience of Hepatitis B by Sub-Saharan Patients in Ivory Coast and France. Sante Publique, 26, 869-878.
- Bekelynck, A. (2015) Private Companies: An Opportunity for Hepatitis B Virus (HBV) Prevention and Care in Ivory Coast in the Wake of HIV/AIDS. Bulletin de la Société de Pathologie Exotique, 108, 57-62. https://doi.org/10.1007/s13149-014-0402-5
- Attia, K.A., Eholié, S., Messou, E., Danel, C., Polneau, S., Chenal, H., et al. (2012) Prevalence and Virological Profiles of Hepatitis B Infection in Human ImmunodeFiciency Virus Patients. World Journal of Hepatology, 4, 218-223. https://doi.org/10.4254/wjh.v4.i7.218
- Kra, O., N'Dri, N., Ehui, E., Ouattara, B. and Bissagnene, E. (2007) Prevalence of HBs Antigen in Blood Donors in the Bouaké Regional Centre of Blood Transfusion in 2001. Bulletin de la Société de Pathologie Exotique, 100, 127-129.
- Kra, O., N'dri, N., Ouattara, B., Kadjo, K., Aba, T. and Bissagnéné, E. (2012) Prevalence of HBs Antigen Carriage in a Population of National Gendarmerie Recruits in Ivory Coast in 2008. Medecine Et Sante Tropicales, 22, 219-220.
- Combe, P., La Ruche, G., Bonard, D., Ouassa, T., Faye-Ketté, H., Sylla-Koko, F., et al. (2001) Hepatitis B and C Infections, Human Immunodeficiency Virus and Other Sexually Transmitted Infections among Women of Childbearing Age in Côte d'Ivoire, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 493-496. https://doi.org/10.1016/S0035-9203(01)90015-X